Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Medicine / Slow-Release-Drug Delivery durch Elvax 40W, um…
JoVE Journal
Medicine

A subscription to JoVE is required to view this content.

JoVE Journal Medicine
Slow-Release-Drug Delivery durch Elvax 40W, um die Ratte Retina
Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
Journal (Medicine)
Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
A
Journal (Medicine)
A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
 
Click here for the English version

Slow-Release-Drug Delivery durch Elvax 40W, um die Ratte Retina: Implikationen für die Behandlung von chronischen Erkrankungen

Article DOI: 10.3791/51563-v • 07:49 min • September 17th, 2014
September 17th, 2014 •
*1, *1, 2,3, 1, 1,2, 2,3,4
1Biotechnology and Applied Clinical Sciences Department, University of L'Aquila, 2ARC Centre of Excellence in Vision Science, 3John Curtin School of Medical Research, Australian National University, 4ANU Medical School, Australian National University
* These authors contributed equally

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Dieses Papier beschreibt, wie Elvax 40W kann als Slow-Release-Verfahren für die Arzneimittelabgabe an die erwachsenen Ratte Netzhaut verwendet werden. Das Protokoll für die Herstellung, Laden und Zuführen des Arzneimittel-Harz-Komplex für das Auge beschrieben.

Tags

Medizin Heft 91 Slow-Release-Drug-Delivery Elvax 40W Co-Polymerharz Auge Netzhaut Ratte APB Netzhautdegeneration Behandlung chronischer Netzhautbedingungen
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter